|
US2006014719A1
|
|
Method for treating neurodegenerative diseases
|
|
WO2006020027A1
|
|
Composition and method for treating hyperproliferative diseases
|
|
EP1765874A1
|
|
Modified pectins, compositions and methods related thereto
|
|
US2004223971A1
|
|
Composition and uses of galectin antagonists
|
|
CA2521649A1
|
|
Composition and uses of galectin antagonists
|
|
US2004121981A1
|
|
Method for controlling angiogenesis in animals
|
|
US6890906B2
|
|
Method for controlling angiogenesis in animals
|
|
CA2451885A1
|
|
Method and material for treating immune diseases
|
|
US6680306B2
|
|
Method for enhancing the effectiveness of cancer therapies
|
|
US6972285B2
|
|
Method of preparing a concentrated solution of a polyglucosamine
|
